Floatz logo

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE

Colon Neoplasm

Seoul National University Bundang HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Colon Neoplasm cohort.

Asset / SponsorPhaseRating
Tranexamic Acid
Assaf-Harofeh Medical Center
Phase 4BB
Eloxatin
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2BB
FLUOROURACILUM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2BB
Cetuximab
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2B
Regorafenib
City of Hope Medical Center
Phase 2B

View all 34 →

Same molecule, other indications

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
78 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
76 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →